BridgeMD
New treatment option for Tobacco Dependence
Official title Harm Reduction for Smokers With Mental Illness
ClinicalTrials.gov ID: NCT06543407
What this study is testing
- What it's testing
- To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigarettes to cope with stress/distress and self-efficacy) as a potential mechanism for behavior change from SWITCH IT
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Diagnostic Criteria (must have one to be eligible):
- Schizophrenia
- Bipolar disorder
- Major Depressive Disorders
- Posttraumatic disorder
You likely can't join if
- Currently residing in a nursing home;
- Current diagnosis of Asthma;
- Cognitive impairment (score \<26 on the Telephone Interview for Cognitive Status (TICS);
- Current use of e-cigarettes (\>once a week);
- Psychiatric instability (hospitalized in the past month);
- Current AND moderate to severe substance use disorder;
See the full eligibility criteria
- Diagnostic Criteria (must have one to be eligible):
- Schizophrenia
- Bipolar disorder
- Major Depressive Disorders
- Posttraumatic disorder
- Other anxiety disorders Additional
- 21 years or older;
- English-speaking;
- Daily smoker (at least 10 cigarettes/day);
- At least one quit attempt in the past 5 years using evidence- based pharmacotherapy or behavioral cessation support;
- Not currently interested in quitting.
- Currently residing in a nursing home;
- Current diagnosis of Asthma;
- Cognitive impairment (score \<26 on the Telephone Interview for Cognitive Status (TICS);
- Current use of e-cigarettes (\>once a week);
- Psychiatric instability (hospitalized in the past month);
- Current AND moderate to severe substance use disorder;
- Pregnant or planning to become pregnant;
- Use of any smoked products other than cigarettes;
- Current unstable medical illness making e-cigarette unsafe (e.g., recent heart attack, cancer);
- Participation in SWITCH IT pilot study.
The study team makes the final eligibility decision.
Where it's taking place
- Louisville, Kentucky, United States
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Louisville, Kentucky, United States; Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.